The year in damages in the US

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The year in damages in the US

Compared to 2013, this year has seen fewer blockbuster damages awards, with none of more than $500 million. But courts still awarded more than $100 million in eight cases

The largest award came out of the District of Delaware, which ordered Philips to pay Masimo $467 million for infringing patents covering technology used in fingertip devices that measure blood oxygen and pulse rates.

This followed the same court in January awarding Edwards LifeScience $394 million for Medtronic CoreValve for infringing patents covering a heart-valve device. The two companies later agreed to settle all global patent litigation in May, with Edwards LifeSciences paying a $750 million one-time payment and ongoing royalty payments.

Carnegie Melon University, ViaSatr, Alfred E Mann Foundation, WesternGeco, Apple and Power Integrations were also awarded damages of more than $100 million in 2014.

This compares with 2013 when two awards of more than $500 million were given. DuPont was ordered to pay $1 billion of damages to Monsanto in a GMO seed case. And Samsung was ordered to pay Apple $599 million in one of two large awards that year.

Managing IP will be publishing an in-depth look at the year in damages in early January. 


Top damages awards 2014

Rank

Against

Beneficiary

Case

Court

Total damages

1

Philips Electronics North America

Masimo Corporation

Masimo Corporation v Philips Electronics North America Corporation

DED

$467m

2

Medtronic CoreValve

Edwards Lifesciences

Edwards Lifesciences v Medtronic Corevalve

DED

$394m

3

Marvell Technology Group

Carnegie Mellon University

Carnegie Mellon University v Marvell Technology Group

PAWD

$367m

4

Space Systems/Loral

ViaSat

Viasat v Space Systems/Loral

CASD

$283m

5

Cochlear Corporation

Alfred E Mann Foundation For Scientific Research

Alfred E Mann Foundation for Scientific Research v Cochlear Corporation

CACD

$131m

6

Samsung Electronics

Apple

Apple v Samsung Electronics

CAND

$120m

7

ION Geophysical Corporation

WesternGeco

WesternGeco v ION Geophysical Corporation

TXSD

$115m

8

Fairchild Semiconductor International

Power Integrations

Power Integrations v Fairchild Semiconductor International

CAND

$105m

9

Google

SimpleAir

SimpleAir v Google

TXED

$85m

10

Sorenson Communications

Ultratec

Ultratec v Sorenson Communications

WIWD

$44m

Source: Docket Navigator

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article